Brief: ChemoMetec Sees 2022/23 Revenue At DKK 485-505 Mln
Sept 14 (Reuters) - Chemometec A/S CHEMM.CO :
* SEES 2022/23 REVENUE AT DKK 485-505 MILLION
* SEES 2022/23 EBITDA AT DKK 245-260 MILLION
* EXPECTS TO INVEST IN 2022/23 APPROX. DKK 70 MILLION IN
PRODUCT
DEVELOPMENT, PATENTS, FACILITIES AS WELL AS PROPERTIES AND
BUILDINGS ETC
Source text for Eikon: ID:nGNE7qtXrz
Further company coverage: CHEMM.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on ChemoMetec A/S
See all newsDenmark's Chemometec Q1 revenue rises 28% on instrument sales
Brief: Chemometec Q1 EBITDA DKK 100.3 Million
Denmark's ChemoMetec lifts FY outlook on strong instrument demand, lower costs
Brief: Chemometec Raises 2026/27 EBITDA Guidance To DKK 335-360 Million
Brief: Chemometec A/S Says Board Initiates Share Buy-Back Based On AGM Authorisation